about
Antidepressant drug effects and depression severity: a patient-level meta-analysisIdentifying moderators of the adherence-outcome relation in cognitive therapy for depression.The process of change in cognitive therapy for depression when combined with antidepressant medication: Predictors of early intersession symptom gainsGender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis.Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.Differential response to depression prevention among a sample of informal caregivers: Moderator analysis of longer-term follow-up trial data.Personality change during depression treatment: a placebo-controlled trial.Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.Client characteristics as moderators of the relation between the therapeutic alliance and outcome in cognitive therapy for depressionScreening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation.The process of change in cognitive therapy for depression: predictors of early inter-session symptom gainsTherapist competence in cognitive therapy for depression: predicting subsequent symptom change.The clinical effectiveness of cognitive therapy for depression in an outpatient clinic.Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy.Cognitive therapy vs medications in the treatment of moderate to severe depression.Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants.Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.Therapist adherence/competence and treatment outcome: A meta-analytic reviewPredictors of patient cognitive therapy skills and symptom change in two randomized clinical trials: the role of therapist adherence and the therapeutic allianceRETRACTED: Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.Gains in employment status following antidepressant medication or cognitive therapy for depression.Two aspects of the therapeutic alliance: differential relations with depressive symptom changeDecision-Making and Depressive Symptomatology.Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings.Predicting Optimal Outcomes in Cognitive Therapy or Interpersonal Psychotherapy for Depressed Individuals Using the Personalized Advantage Index Approach.Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective studyCan the randomized controlled trial literature generalize to nonrandomized patients?Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression.A re-examination of process-outcome relations in cognitive therapy for depression: Disaggregating within-patient and between-patient effects.The therapeutic alliance and therapist adherence as predictors of dropout from cognitive therapy for depression when combined with antidepressant medicationResearch setting versus clinic setting: Which produces better outcomes in cognitive therapy for depression?Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy.Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy.Convergence and divergence in the delivery of cognitive therapy in two randomized clinical trials.Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.In cognitive therapy for depression, early focus on maladaptive beliefs may be especially efficacious for patients with personality disordersAntidepressant medications v. cognitive therapy in people with depression with or without personality disorder.Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms.The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration.Pretreatment anxiety predicts patterns of change in cognitive behavioral therapy and medications for depression.
P50
Q24598580-BD2E54DC-30B3-4F2D-BE7C-B76F6A8A2823Q27334150-1D362B55-DC20-4A19-95D6-D1465728321EQ30525276-D824F734-347C-4E7E-8AD9-8ECC0170BC65Q30870493-6C38CBF8-4307-4C55-BDB9-E5175E93300EQ30996080-CB6FF4FE-3521-4D86-BD18-87FF5525DF42Q31004403-60C50421-97FB-443D-96A7-3CE4E31AFD63Q33562048-87DE8FC9-3650-41DF-B8B8-D4CDA4539E85Q33605850-AE163993-C717-4632-BE0F-0C3CED4881A6Q33778084-573F1C03-02B8-45D7-8BB8-2BA621C14E5FQ33876216-B3C62F5B-FDDC-4190-B720-B8F8317E23D6Q33886618-A5905E67-5D05-4205-A397-98DCC21F3B05Q33894374-C4E30621-6C5A-4403-AD29-62E51AB80E30Q33926591-4FC9BB19-8ACD-47DA-BBAE-811C5469A84DQ34147129-987C230F-B06C-44DC-AB2A-ADF6A4678280Q34408868-59F17C36-2038-490D-8E3E-83302CE91D66Q34547420-E2AB5152-CEEC-4671-A12B-5BE1E1A24CD1Q34556472-8EC2CF32-4AD2-446B-BBF5-44C4E11E68D1Q34581976-8F6FA891-7FCB-4BCC-B411-D4AE40A7DE12Q34600612-664EB246-0BCE-4812-A0A1-A05E27A75AF8Q34664030-F5D5C2F7-8E6F-4116-ADE9-ED5C79B943B8Q34691663-25124099-3A74-409F-92FC-6D87FB03D30AQ35070622-7AD4EE3F-4C3C-42B2-9072-0B5679D1857FQ35094108-A703B500-7090-4D28-8F5C-F8E3109521C9Q35586100-246C558C-86B6-45EF-A616-234492A3B786Q35837058-4D3232E5-545E-4FF9-8549-8AAF6C5E1DEBQ35967580-B8102DA7-1C0D-424E-98B8-502F874645D0Q36040644-0C30B53B-5A86-4170-902E-D80ECE115C13Q36082786-E4AA0B22-1BB5-45C8-A123-24F8B93F22E6Q36171066-F223B145-DE15-42A1-9F6A-53CADB92EB4DQ36372648-3506F021-E4E0-4021-98A3-EFBA7257BB0EQ36866596-BACBFBEA-B157-40DE-94B7-A8BD32036A95Q36935348-75B39DCA-14A5-45CB-B7CB-DB5880899A3DQ37014627-D89529F8-52D3-481D-9CDE-67FEE14DEF10Q37032748-FCEC7814-A665-4E83-9AEB-B77BC3844F81Q37068258-E82CAD80-3F4F-441E-9C30-8863F4AFCA5CQ37073590-9AD402E0-F7B2-4010-B1AF-70A10189D5A3Q37193416-6BB2FA17-0AC1-4B1D-8091-1E421A5321D1Q37266134-4AE3F619-2650-4BEF-82C1-5BAEE77E9C9AQ37452489-95328816-E631-464A-B1CD-57C1C71AB145Q37555911-8BAE2127-58DB-4737-AB27-1EFC3BB766FD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robert J. DeRubeis
@ast
Robert J. DeRubeis
@en
Robert J. DeRubeis
@es
Robert J. DeRubeis
@nl
Robert J. DeRubeis
@sl
type
label
Robert J. DeRubeis
@ast
Robert J. DeRubeis
@en
Robert J. DeRubeis
@es
Robert J. DeRubeis
@nl
Robert J. DeRubeis
@sl
prefLabel
Robert J. DeRubeis
@ast
Robert J. DeRubeis
@en
Robert J. DeRubeis
@es
Robert J. DeRubeis
@nl
Robert J. DeRubeis
@sl
P106
P1153
7003716117
P21
P31
P496
0000-0003-3129-0277